• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes

    Author(s)
    MARTIN, JL
    VELURAJA, K
    ROSS, K
    JOHNSON, LN
    FLEET, GWJ
    RAMSDEN, NG
    BRUCE, I
    ORCHARD, MG
    OIKONOMAKOS, NG
    PAPAGEORGIOU, AC
    LEONIDAS, DD
    TSITOURA, HS
    Griffith University Author(s)
    Martin, Jennifer
    Year published
    1991
    Metadata
    Show full item record
    Abstract
    abstract: The T-state crystal structure of the glucose-phosphorylase b complex has been used as a model for the design of glucose analogue inhibitors that may be effective in the regulation of blood glucose levels. Modeling studies indicated room for additional atoms attached at the C1-/3 position of glucose and some scope for additional atoms at the Cl-a position. Kinetic parameters were determined for a-D-glucose: K{ = 1.7 mM, Hill coefficient n = 1.5, and a (synergism with caffeine) = 0.2. For /3-D-glucose, K{ = 1A mM, n = 1.5, and a = 0.4. More than 20 glucose analogues have been synthesized and tested in kinetic ...
    View more >
    abstract: The T-state crystal structure of the glucose-phosphorylase b complex has been used as a model for the design of glucose analogue inhibitors that may be effective in the regulation of blood glucose levels. Modeling studies indicated room for additional atoms attached at the C1-/3 position of glucose and some scope for additional atoms at the Cl-a position. Kinetic parameters were determined for a-D-glucose: K{ = 1.7 mM, Hill coefficient n = 1.5, and a (synergism with caffeine) = 0.2. For /3-D-glucose, K{ = 1A mM, n = 1.5, and a = 0.4. More than 20 glucose analogues have been synthesized and tested in kinetic experiments. Most were less effective inhibitors than glucose itself and the best inhibitor was a-hydroxymethyl-1- deoxy-D-glucose (Kt = 1.5 mM, n = 1.3, a = 0.4). The binding of 14 glucose analogues to glycogen phosphorylase b in the crystal has been studied at 2.4-A resolution and the structure have been refined to crystallographic R values of less than 0.20. The kinetic and crystallographic studies have been combined to provide rationalizations for the apparent affinities of glucose and the analogues. The results show the discrimination against /3-D-glucose in favor of a-D-glucose is achieved by an additional hydrogen bond made in the a-glucose complex through water to a protein group and an unfavorable environment for a polar group in the /3 pocket. The compound a-hydroxymethyl-l-deoxy-D-glucose has an affinity similar to that of glucose and makes a direct hydrogen bond to a protein group. Comparison of analogues with substituent atoms that have flexible geometry (e.g., 1-hydroxyethyl /3-D-glucoside) with those whose substituent atoms are more rigid (e.g., /3-azidomethyl-1 -deoxyglucose or /3-cyanomethyl-1 -deoxyglucose) indicates that although all three compounds make similar polar interactions with the enzyme, those with more rigid substituent groups are better inhibitors. In another example, a-azidomethyl-1 -deoxyglucose was a poor inhibitor. In the crystal structure the compound made several favorable interactions with the enzyme but bound in an unfavorable conformation, thus providing an explanation for its poor inhibition. Attempts to utilize a contact to a buried aspartate group were partially successful for a number of compounds (/3-aminoethyl, /3-mesylate, and /3-azidomethyl analogues). The /3 pocket was shown to bind gentiobiose (6-0-/3-D-glucopyranosyl-Dglucose), indicating scope for binding of larger side groups for future studies.
    View less >
    Journal Title
    Biochemistry
    Volume
    30
    Issue
    42
    DOI
    https://doi.org/10.1021/bi00106a006
    Subject
    Medicinal and biomolecular chemistry
    Biochemistry and cell biology
    Biochemistry and cell biology not elsewhere classified
    Medical biochemistry and metabolomics
    Publication URI
    http://hdl.handle.net/10072/378685
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander